These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2091882

  • 1. Effects of captopril on urinary excretion of albumin and prostaglandins in patients with diabetic nephropathy.
    Tajiri Y, Umeda F, Inoguchi T, Kunisaki M, Nawata H, Ninomiya H, Asano T.
    Diabetes Res; 1990 Mar; 13(3):145-50. PubMed ID: 2091882
    [Abstract] [Full Text] [Related]

  • 2. Reduction of urinary albumin excretion by thromboxane synthetase inhibitor, OKY-046, through modulating renal prostaglandins in patients with diabetic nephropathy.
    Tajiri Y, Inoguchi T, Umeda F, Nawata H.
    Diabetes Res Clin Pract; 1990 Mar; 10(3):231-9. PubMed ID: 2073870
    [Abstract] [Full Text] [Related]

  • 3. Effects of captopril on the urinary excretion of prostanoids and kallikrein in spontaneously hypertensive rats.
    Säynävälammi P.
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):285-90. PubMed ID: 3541494
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandins and diabetic nephropathy.
    Umeda F, Kuroki T, Nawata H.
    J Diabetes Complications; 1995 Oct; 9(4):334-6. PubMed ID: 8573760
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition.
    Vora JP, Leese GP, Peters JR, Owens DR.
    J Diabetes Complications; 1996 Oct; 10(2):88-93. PubMed ID: 8777336
    [Abstract] [Full Text] [Related]

  • 6. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats.
    Säynävälammi P, Pörsti I, Nurmi AK, Seppälä E, Laitinen LA, Manninen V, Ylitalo P, Vapaatalo H.
    Scand J Urol Nephrol Suppl; 1984 Oct; 79():23-7. PubMed ID: 6089314
    [Abstract] [Full Text] [Related]

  • 7. Effects of cilostazol, a phosphodiesterase inhibitor, on urinary excretion of albumin and prostaglandins in non-insulin-dependent diabetic patients.
    Watanabe J, Sako Y, Umeda F, Nawata H.
    Diabetes Res Clin Pract; 1993 Oct; 22(1):53-9. PubMed ID: 8137717
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of decreased albuminuria caused by angiotensin converting enzyme inhibitor in early diabetic nephropathy.
    Imanishi M, Yoshioka K, Okumura M, Konishi Y, Tanaka S, Fujii S, Kimura G.
    Kidney Int Suppl; 1997 Dec; 63():S198-200. PubMed ID: 9407458
    [Abstract] [Full Text] [Related]

  • 9. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
    Insua A, Ribstein J, Mimran A.
    Postgrad Med J; 1988 Dec; 64 Suppl 3():59-62; discussion 90-2. PubMed ID: 3074298
    [Abstract] [Full Text] [Related]

  • 10. Effect of captopril on renal hemodynamics and renal prostaglandins in early type II diabetic patients with normo-or microalbuminuria.
    Xiao X, Gan P, Yu M, Li J, Han Q.
    Chin Med Sci J; 1996 Sep; 11(3):170-3. PubMed ID: 9387403
    [Abstract] [Full Text] [Related]

  • 11. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
    Agnoli GC, Borgatti R, Cacciari M, Lenzi P, Marinelli M, Stipo L.
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
    [Abstract] [Full Text] [Related]

  • 12. The 5-HT2 receptor antagonist sarpogrelate reduces urinary and plasma levels of thromboxane A2 and urinary albumin excretion in non-insulin-dependent diabetes mellitus patients.
    Ogawa S, Takeuchi K, Sugimura K, Sato C, Fukuda M, Lee R, Ito S, Sato T.
    Clin Exp Pharmacol Physiol; 1999 Feb; 26(5-6):461-4. PubMed ID: 10386239
    [Abstract] [Full Text] [Related]

  • 13. Involvement of prostaglandins in the action of captopril in type II diabetic patients.
    Koev D, Zacharieva S, Andonova K.
    Exp Clin Endocrinol; 1989 Apr; 93(1):11-8. PubMed ID: 2661245
    [Abstract] [Full Text] [Related]

  • 14. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P, Eiam-Ong S, Suwanwalaikorn S.
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [Abstract] [Full Text] [Related]

  • 15. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
    Lazarevic G, Antic S, Vlahovic P, Djordjevic V, Zvezdanovic L, Stefanovic V.
    Ren Fail; 2007 Feb; 29(2):199-205. PubMed ID: 17365936
    [Abstract] [Full Text] [Related]

  • 16. Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy.
    O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH.
    J Hum Hypertens; 1993 Aug; 7(4):327-32. PubMed ID: 8410923
    [Abstract] [Full Text] [Related]

  • 17. Effect of tranilast in early-stage diabetic nephropathy.
    Soma J, Sato K, Saito H, Tsuchiya Y.
    Nephrol Dial Transplant; 2006 Oct; 21(10):2795-9. PubMed ID: 16820373
    [Abstract] [Full Text] [Related]

  • 18. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [Abstract] [Full Text] [Related]

  • 19. [Urinary albumin excretion in non-insulin-dependent diabetic patients. Effects of an angiotensin-converting enzyme inhibitor].
    Durruty P, Tapia JC, Ugarte C, Pérez E, Krause P, Soto N, García de los Ríos M.
    Rev Med Chil; 1996 Sep; 124(9):1036-44. PubMed ID: 9197016
    [Abstract] [Full Text] [Related]

  • 20. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C, Ciabattoni G, Remuzzi G, Gotti E, Bombardieri S, Di Munno O, Tartarelli G, Cinotti GA, Simonetti BM, Pierucci A.
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.